Exelixis
EXEL
#1647
Rank
$13.19 B
Marketcap
$52.49
Share price
1.72%
Change (1 day)
24.32%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company